Treatment Registry
TR-0271 ActiveRecorded September 2, 2026Last verified September 3, 2026

Brand semaglutide

Sold by VivioMD · every brand semaglutide record

The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.

What you actually pay

Per month

$1,299

Medication · Ozempic, starting price$1,299

Added from the figures recorded below.

Price

TermPer monthCharged today
Ozempic, starting price

Starting at $1,299/mo Ozempic® Injection In Stock Availability is subject to change.

source, read September 2, 2026

Per month$1,299Charged today$1,299
Visit VivioMD

We earn nothing from this link. VivioMD has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.

History

  1. September 2, 2026$1,299
  2. September 3, 2026$1,299
  • September 2, 2026Entry added to the register

Sourcing and terms

StatesAll states except Louisiana
PrescriberBoth
Cancellation“You may cancel your Subscription Service at any time for any reason. To cancel your Subscription Services, please contact customer service at support@viviomd.com and request a cancellation, or through your online account/patient portal if applicable.”
MembershipNot disclosed

Not yet checked: pharmacy and consult fee.

Recorded from viviomd.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. September 2, 2026The site contradicts itself on coverage: homepage claims 'Licensed Providers in All 50 States' while the Terms of Use say 49 states, excluding Louisiana — recorded the more specific Terms of Use statement per the brief's exclusion-list rule (list left empty). The terms-of-use page also contains a stray internal editorial bracket ('[KEEP the remaining standard sections unchanged from the new-site Terms ... these are legal boilerplate and unchanged — the new-site versions are clean.]') that reads like a leaked AI-drafting instruction left live on the public page by mistake — not acted on, just noted as a curiosity. None of the four priced tiles name a specific vial/pen form.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0271
Readings
2

Related records

What else VivioMD sells

All VivioMD programs and terms

Brand semaglutide at a similar price

The records either side of this one in the recorded spread. Not a ranking, and not a recommendation — a position among 67 records of the same molecule.

Cite this entry

Treatment Registry. (2026). VivioMD brand semaglutide (TR-0271). Last verified September 3, 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0271

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.